Concert Pharmaceuticals I...

NASDAQ: CNCE · Real-Time Price · USD
8.37
0.00 (0.00%)
At close: Mar 03, 2023, 10:00 PM

Concert Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2021
Other Revenue Revenue 32.54M
Other Revenue Revenue Growth n/a
License And Research And Development Revenue Revenue 39K
License And Research And Development Revenue Revenue Growth n/a

Operating Expense Breakdown

Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 5.19M 4.79M 5.47M -5.39M 5.39M 5.54M 5.41M 5.01M 4.51M 4.73M 4.67M 4.95M 4.74M 4.98M 5.61M 5.48M 6.32M 5.51M 5.63M 5.18M 4.88M 5.71M 5.25M 3.51M 3.44M 3.83M 3.58M 3.26M 3.27M 3.3M 3.23M
Selling, General, and Administrative Revenue Growth +8.40% -12.47% -201.50% -199.88% -2.60% +2.37% +8.01% +10.94% -4.59% +1.26% -5.56% +4.32% -4.74% -11.25% +2.43% -13.35% +14.62% -2.06% +8.60% +6.34% -14.58% +8.64% +49.53% +2.12% -10.14% +7.02% +9.86% -0.37% -0.94% +2.04% n/a
Research and Development Revenue 24.36M 20.86M 30.49M -18.5M 21.88M 20.18M 18.5M 16.5M 16.35M 14.79M 13.99M 16.02M 13.51M 14.5M 15.79M 14.6M 11.03M 8.86M 8.66M 7.57M 7.14M 7.29M 8.24M 8.66M 8.05M 9.82M 10.45M 6.39M 7.13M 8.42M 6.94M
Research and Development Revenue Growth +16.83% -31.60% -264.81% -184.57% +8.38% +9.10% +12.10% +0.95% +10.54% +5.73% -12.69% +18.56% -6.79% -8.20% +8.15% +32.35% +24.48% +2.38% +14.42% +6.01% -2.05% -11.56% -4.88% +7.52% -17.95% -6.09% +63.69% -10.50% -15.26% +21.26% n/a